Abstract
Background:
To determine whether prostate cancers detected in the anterior vs posterior zones impact clinicopathological features and patient outcomes. This information could potentially affect clinical management.
Methods:
A retrospective pathological review of 1528 radical prostatectomy specimens submitted between 1989 and 2011 was completed. Specimens were characterized as anterior zone vs posterior zone based on index tumor and predominant tumor volume location. The chi-square test was used to determine associations between tumor location and categorical patient features. Kaplan–Meier unadjusted analysis was used to compare biochemical recurrence-free and overall survival.
Results:
Tumors occurred predominantly in the anterior location in 155 (10.1%) of specimens. There was no difference between mean age, body mass index, racial distribution, family history, number of previous biopsies, clinical Gleason sum or pathological stage in the two groups. Fewer patients had clinically palpable disease in the anterior tumor group, 28.8% vs 40.7% (P=0.0150). Pretreatment PSA was lower in the anterior tumor group. Total tumor volume did differ with anterior tumors having a mean 8.3 cc vs 5.6 cc (P<0.0001) size and a higher incidence of positive margins (P=0.0008). There were no differences in biochemical recurrence-free or overall survival.
Conclusions:
Despite the potential for adverse pathological features in anterior-based disease, there appears to be no demographic predilection, notable delay in diagnosis or significant difference in survival outcomes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Stephenson AJ, Scardino PT, Eastham JA, Dotan ZA, Fearn PA, Kattan MW et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 2006; 98: 715–717.
Koppie TM, Bianco FJ, Kuroiwa K, Reuter VE, Guillonneau B, Eastham JA et al. The clinical features of anterior prostate cancer. BJU 2006; 98: 1167–1172.
Furusato B, Gao CL, Ravindranath L, Chen Y, Cullen J, McLeod DG et al. Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer. Mod Pathol 2008; 21: 67–75.
Rosen P, Pfisters D, Young D, Petrovics G, Chen Y, Cullen J et al. Differences in frequency of ERG oncogene expression between index tumors of Caucasian and African American patients with prostate cancer. Urology 2012; 80: 749–753.
Bott SR, Young MP, Kellet MJ, Parkinson MC, Contributors to the UCL Hospitals’ Trust Radical Prostatectomy Database. Anterior prostate cancer: is it more difficult to diagnose? BJU Int 2002; 89: 886–889.
Wright JL, Ellis WJ . Improved prostate cancer detection with anterior apical biopsies. Urol Oncol 2006; 24: 492–495.
Meng MV, Franks JH, Presti JC, Shinohara K . The utility of apical anterior horn biopsies in prostate cancer detection. Urol Oncol 2003; 21: 361–365.
Iremashvili V, Pelaez L, Jorda M, Manoharan M, Rosenberg DL, Soloway MS . Prostate cancers of different zonal origin: clinicopahtological characteristics and biochemical outcomes after radical prostatectomy. Urology 2012; 80: 1063–1069.
Tokuda Y, Carlino LJ, Gopalan A, Tickoo SK, Kaag MG, Guillonneau B et al. Prostate cancer topography and patterns of lymph node metastasis. Am J Surg Path 2010; 34: 1862–1876.
Al-Ahmadie HA, Tickoo SK, Olgac S, Gopalan A, Scardino PT, Reuter VE et al. Anterior-predominant prostate tumors: zone of origin and pathologic outcomes after radical prostatectomy. Am J Surg Path 2008; 32: 229–235.
Puech P, Potiron E, Lemaitre L, Leroy X, Haber GP, Crouzet S et al. Dynamic contrast-enhanced magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens. Urology 2009; 74: 1094–1099.
Ouzzane A, Puech P, Lemaitre L, Leroy X, Nevoux P, Betrouni N et al. Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading. Urology 2011; 78: 1356–1362.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Mygatt, J., Sesterhenn, I., Rosner, I. et al. Anterior tumors of the prostate: clinicopathological features and outcomes. Prostate Cancer Prostatic Dis 17, 75–80 (2014). https://doi.org/10.1038/pcan.2013.54
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/pcan.2013.54
Keywords
This article is cited by
-
Comparison of malignancy and spatial distribution between latent and clinical prostate cancer: an 8-year biopsy study
European Journal of Medical Research (2022)
-
Prognostic performance of magnetic resonance imaging-guided biopsy in defining prostate cancer anterior lesions
World Journal of Urology (2021)
-
Clinicopathologic features and outcomes of anterior-dominant prostate cancer: implications for diagnosis and treatment
Prostate Cancer and Prostatic Diseases (2020)
-
Anterior gland focal cryoablation: proof-of-concept primary prostate cancer treatment in select men with localized anterior cancers detected by multi-parametric magnetic resonance imaging
BMC Urology (2019)
-
Multi-parametric MR imaging of the anterior fibromuscular stroma and its differentiation from prostate cancer
Abdominal Radiology (2017)